0
0.5
1
1.5
2+
Mortality, ventilation, or..
96%
Improvement
Relative Risk
Aspirin for COVID-19 Kevorkian et al. LATE TREATMENT
Is late treatment with aspirin + combined treatments beneficial for COVID-19?
Retrospective 68 patients in France (January - November 2020)
Lower progression with aspirin + combined treatments (p=0.0005)
c19early.org
Kevorkian et al., J. Infection, June 2021
Favors aspirin
Favors control